Evaluation Of Serum MIF Level in SLE Patients
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Systemic Lupus Erythematosus
Related studies linked through entity extraction aliases.
Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE1
Lupus Education Alliance Program
- Status
- TERMINATED
- Phase
- NA
COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
A Study of a Single Ascending Dose Study of DS-7011a in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Clinical and Diagnostic Value of Ribosomal p2 Autoantibodies in Systemic Lupus Erythematosus
- Status
- UNKNOWN
- Phase
- N/A
The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)
- Status
- COMPLETED
- Phase
- PHASE2
The Effect of Deep Breathing and Transcutaneus Electrical Nerve Stimulation on Heart Rate Variability
- Status
- UNKNOWN
- Phase
- NA
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered Mosunetuzumab to Participants With Systemic Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE1
Clonal Hematopoiesis of Indeterminate Potential and Accelerated Atherosclerosis in Systemic Lupus Erythematosus
- Status
- COMPLETED
- Phase
- N/A
The Genital Tract Microflora in Women With Systemic Lupus Erythematosus (SLE) and Immunoglobulin A (IgA) Nephropathy.
- Status
- UNKNOWN
- Phase
- N/A
A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Erythematosus
- Status
- TERMINATED
- Phase
- PHASE2
Breaking Implicit Bias Habits: An Individuation Pilot Study In Rheumatology
- Status
- COMPLETED
- Phase
- NA
Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Slit2 in Systemic Lupus Erythematosus and Systemic Sclerosis Patients
- Status
- UNKNOWN
- Phase
- N/A
Exercise and Nutrition Recommendations for Patients Using Glucocorticoids (ENRG)
- Status
- UNKNOWN
- Phase
- NA
PRV-3279-2a Trial in Systemic Lupus
- Status
- TERMINATED
- Phase
- PHASE2
Reappraisal of the Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus Erythematosus
- Status
- UNKNOWN
- Phase
- PHASE3
IL17 in Systemic Lupus Erythematosus Patients: Association With Disease Activity and Organ Damage
- Status
- UNKNOWN
- Phase
- N/A
Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2